Intellia, beginning treatment in CRISPR study, secures Gates Foundation backing
Bio Pharma Dive
NOVEMBER 11, 2020
The biotech won a grant from the foundation two days after dosing the first patient in a study of an in vivo CRISPR medicine, a milestone for the company and the technology.
Let's personalize your content